Editorials |
From the Section of Cardiovascular Medicine and the Robert Wood Johnson Clinical Scholars Program, Department of Internal Medicine; Section of Health Policy and Administration, School of Public Health, Yale University School of Medicine; and Center for Outcomes Research and Evaluation, Yale–New Haven Hospital, New Haven, Conn.
Correspondence to Dr Harlan M. Krumholz, Yale University School of Medicine, 333 Cedar St, PO Box 208088, New Haven, CT 06520-8088. E-mail harlan.krumholz{at}yale.edu
Key Words: Editorials outcomes assessment publishing
The launch of Circulation: Cardiovascular Quality and Outcomes occurs during a time in which the healthcare system is simultaneously achieving its greatest triumphs and facing its most daunting challenges. As a profession, we are manifesting remarkable advances in our ability to understand, prevent, and treat cardiovascular disease and stroke, yet there are vast gaps in our ability to preempt, mitigate, and cure these conditions. Often, these gaps derive from a lack of evidence about how best to provide care and public health interventions, how best to prioritize resources, and how best to work collaboratively with and in the best interests of the public and our patients.
Scholarship is needed to promote improvements in cardiovascular and stroke health and health care, focusing on the end results of our efforts. Outcomes research provides evidence to support efforts to achieve safe, effective, efficient, equitable, timely, and patient-centered care.1 We envision the journal as a venue for content of consequence—a home for outstanding science, commentary, and novel ideas. The journal will be a catalyst for good science with practical implications and a means to inspire junior people to engage in scholarly activities that have practical applicability.
The mission of Circulation: Cardiovascular Quality and Outcomes is to improve clinical decision making, population health, and healthcare policy. Moreover, Circulation: Cardiovascular Quality and Outcomes aspires to play a leading role in strengthening the global community dedicated to eliminating the epidemic of cardiovascular disease and stroke. This will be accomplished through a format that promotes scholarship, education, and constructive debate. The audience for this journal includes researchers, clinicians, policymakers, administrators, health plan executives, and government agency professionals.
The journals name is noteworthy. As part of the Circulation family, it occupies a place within a strong tradition of excellence and an association with the American Heart Association (AHA) and with the American Stroke Association. The term Quality and Outcomes is intended to convey our interest in how care and preventive strategies are delivered and what is achieved for patients and the public. The journal will be a home for contributions that span epidemiology, clinical epidemiology, management sciences, economics, statistics, health policy, quality improvement, and other fields. The publications will have a common link to practical importance, with the possibility of informing practice and policy.
For the cardiovascular and stroke community, this journal completes the quartet of initiatives at the AHA to support the growth and development of outcomes research and to elevate the quality of cardiovascular care. In 1999, the Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke was launched. Several years later, the AHA formed the Interdisciplinary Working Group on Quality of Care and Outcomes Research to allow a governing structure to oversee organizational efforts in this area. This year, the AHA funded outcomes research centers and transformed the Interdisciplinary Working Group into an official Council, strengthening its position within the AHA. This journal represents a fourth key step in supporting the outcomes research community and extending its impact.
The issues addressed by Circulation: Quality of Care and Outcomes extend far beyond national boundaries. Accordingly, there will be a concerted effort to include a strong international presence that will foster a global community with shared values and goals. Moreover, international differences in structures and processes of care provide opportunities for mutual learning and take advantage of the natural experiments resulting from these variations in approach.
Partnerships are an important aspect of this journal. Our primary goal is to bring together new perspectives and information; an additional goal is to facilitate communication about resources and interests between funders and the research community. To accomplish this, we will seek contributions from varied sources, including governmental agencies, foundations, and nonprofit associations that are interested in outcomes research. We will also work with partners to disseminate information about relevant activities and publications that do not traditionally make their way into the peer-reviewed journals. All of these efforts will position the journal as a resource to investigators as well as consumers of research information.
We anticipate that the articles and contributions will describe many types of methodologies, including mixed methods and qualitative research, and more traditional quantitative research. The theme that will unite these areas is the focus on improving patient- and population-level decision making and, ultimately, patient outcomes and population health at an affordable cost. As a natural extension of the multidisciplinary nature of outcomes research, this journal will exist at the intersection of basic biomedical research, epidemiology, clinical research, social sciences, and the humanities (ethics). Circulation: Cardiovascular Quality and Outcomes will focus not just on what we should do but how best to do it, with an emphasis on implementation science.
In evaluating submitted articles, the Editors will be asking whether they extend our understanding of an issue in an important way, illuminate unstudied issues, question conventional wisdom and current approaches, and equip readers with essential information to improve the status quo. The best articles will influence practice and policy, providing evidence that supports decisions for individual patients, the healthcare system, and society.
Circulation: Cardiovascular Quality and Outcomes will be defined by the following sections:
The editorial processes for Circulation: Cardiovascular Quality and Outcomes will be based on rapid evaluation and publication, as well as the use of online publication to provide timely release and augment the range of published contributions and supplementary material.
The journals Deputy Editor is Dr John Spertus, and the Associate Editors are Drs Frederick Masoudi, Sharon-Lise Normand, and John Rumsfeld. These outstanding investigators share a strong commitment to providing a rapid and fair evaluation of every submission. Dr Jerome Kassirer, a former Editor of the New England Journal of Medicine, is a Senior Advisor. We have also assembled a talented group of individuals to serve on the editorial board, each of whom has made a considerable commitment to helping achieve the journals goals. In addition, we have an international board that will help us to achieve a global perspective. We plan to rotate our editorial board positions frequently to provide the opportunity for a large number of interested members to participate.
To ensure fair review, we have also instituted a rigorous process, similar to that used by Circulation, in which Guest Editors will assist in the evaluation of submissions from our Editors and the Editors institutions. Such submissions will be routed to a Senior Guest Editor who will then assign the work to a Guest Editor, without involvement of the journals Editors. The Guest Editors will obtain reviewers and make a decision about the manuscript. This process insulates the decisions from any influence of the Editor or Associate Editors.
Our first issue has original articles that provide a sense of future contributions. The cost-effectiveness analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial provides a critical perspective on the value of an initial percutaneous coronary intervention strategy for patients with stable coronary disease.2 The article by Arnold and colleagues introduces a tool to inform patients about the risks and benefits of percutaneous coronary intervention and presents a rigorous evaluation of its impact on care from the institutional and patient perspectives.3 Keenan and coauthors present the science behind a National Quality Forum–approved measure of 30-day readmission rates for patients discharged after a heart failure admission, a measure that could become publicly reported and turn attention to the high readmission rates for these patients.4 Mahoney and colleagues investigate the costs of care associated with the burden of arteriosclerosis, providing estimates that can inform policy and be applied by other investigators seeking an economic perspective on these patients.5 Angell and coauthors present an analysis of prevalence and control of hypertension in New York City, with attention to some disturbing predictors of elevated readings, such as access to care.6 These articles, surrounding topics of consequence and resulting from rigorously designed research, are representative of what we seek to provide in every issue. The 3 editorials place articles in context and provide perspective on their importance and implications.7–9 The tutorial by Austin provides needed assessment and guidance on propensity analysis, a technique that is growing in popularity.10 Finally, 2 commentaries will interpret the practical implications of recent, high-visibility trials (Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] and PeriOperative ISchemic Evaluation [POISE]), providing some guidance for clinical practice and policy.11,12
How can you contribute to the journals success? We are open to your ideas about how to continually improve; our ultimate success will depend on the goodwill, enthusiasm, and involvement of our community and the sense that this initiative will only succeed through our joint efforts. We also need for our readers and contributors to advocate for libraries to subscribe, and for AHA members to choose it as one of their member benefits. We also want to support the use of an electronic table of contents for the journal. (To sign up, please visit http://circoutcomes.ahajournals.org/subscriptions/etoc.dtl.) We would like for you to consider the journal as an outstanding venue for your contributions (see http://circ.ahajournals.org/misc/ifora_outcomes.shtml for instructions for authors). Finally, we, as a community, have a responsibility to make the journal worth reading.
The ultimate success of Circulation: Cardiovascular Quality and Outcomes will not be in the pages published but in the way that the journal supports ideas and scholarship that lead to tangible benefits for patients and populations. With this issue, we welcome you to the first journal dedicated to quality of care and outcomes research in cardiovascular disease and stroke. We have audacious hopes for this endeavor; please join us in making it a success.
| Acknowledgments |
|---|
None.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Weintraub WS, Boden WE, Zhang Z, Kolm P, Zhang Z, Spertus JA, Hartigan P, Veledar E, Jurkovitz C, Bowen J, Maron DJ, O'Rourke R, Dada M, Teo KK, Goeree R, Barnett P. Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients. Circ Cardiovasc Qual Outcomes. 2008; 1: 12–20.
3. Arnold SV, Decker CJ, Ahmad H, Olabiyi O, Mundluru S, Reid KJ, Soto GE, Gansert S, Spertus JA. Converting the informed consent from a perfunctory process to an evidence-based foundation for patient decision making. Circ Cardiovasc Qual Outcomes. 2008; 1: 21–28.
4. Keenan PS, Normand S-LT, Lin Z, Drye EE, Bhat KR, Ross JS, Schuur JD, Stauffer BD, Bernheim SM, Epstein AJ, Wang YF, Herrin J, Chen J, Federer JJ, Mattera JA, Wang Y, Krumholz HM. An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes. 2008; 1: 29–37.
5. Mahoney EM, Wang K, Cohen DJ, Hirsch AT, Alberts MJ, Eagle K, Mosse F, Jackson J, Steg G, Bhatt DL. One-year costs in patients with a history of or at risk for atherothrombosis in the United States. Circ Cardiovasc Qual Outcomes. 2008; 1: 38–45.
6. Angell SY, Garg RK, Gwynn RC, Bash LD, Thorpe LE, Frieden TR. Prevalence, awareness, treatment, and predictors of control of hypertension in New York City. Circ Cardiovasc Qual Outcomes. 2008; 1: 46–53.
7. Bonow RO. Measuring quality in heart failure: do we have the metrics? Circ Cardiovasc Qual Outcomes. 2008; 1: 9–11.
8. Kirtane AJ, Cohen DJ. When is better not good enough? Insights from the COURAGE economic study. Circ Cardiovasc Qual Outcomes. 2008; 1: 4–6.
9. Rao SV, Kim SYH. Informing the consent process. Circ Cardiovasc Qual Outcomes. 2008; 1: 7–8.
10. Austin PC. Report card on propensity-score matching in the cardiology literature from 2004 to 2006: a systematic review. Circ Cardiovasc Qual Outcomes. 2008; 1: 62–67.
11. Auerbach A. Changing the practice of perioperative cardioprotection: perioperative β-blockers after POISE (PeriOperative ISchemic Evaluation). Circ Cardiovasc Qual Outcomes. 2008; 1: 58–61.
12. Taylor AJ, Nissen SE. Preliminary observations from preliminary trial results: have we finally had enough? Circ Cardiovasc Qual Outcomes. 2008; 1: 54–57.
This article has been cited by other articles:
![]() |
H. M. Krumholz One Year at Circulation: Cardiovascular Quality and Outcomes Circ Cardiovasc Qual Outcomes, September 1, 2009; 2(5): 399 - 401. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Home | Subscriptions | Archives | Feedback | Authors | Help | Circulation Journals Home | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |